Inventor · disambiguated record
Roy E. Twyman
Also filed as: TWYMAN ROY E
12 granted patents·13 pending applications·160 citations·filing 1994–2024
91Inventor score
Files withJANSSEN PHARMACEUTICA NV7ORTHO MCNEIL PHARM INC5PLATA-SALAMAN CARLOS R4TWYMAN ROY E3UNIV UTAH RES FOUND2
Top patents by PatentIndex Score
25 records- 0191US7078436B2Carbamate compounds for use in preventing or treating anxiety disordersORTHO MCNEIL PHARM INC·Filed 2002·Granted Jul 18, 2006·36 cites·22 claims
- 0289US6589985B2Carbamate compounds for use in preventing or treating movement disordersORTHO MCNEIL PHARM INC·Filed 2002·Granted Jul 8, 2003·39 cites·23 claims
- 0388US6562867B2Carbamate compounds for use in preventing or treating bipolar disorderORTHO MCNEIL PHARM INC·Filed 2002·Granted May 13, 2003·34 cites·23 claims
- 0486US2025288584A1Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their useJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 0585US2025041301A1Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their useJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 0680US6541513B2Carbamate compounds for use in preventing or treating psychotic disordersORTHO MCNEIL PHARM INC·Filed 2002·Granted Apr 1, 2003·14 cites·22 claims
- 0779US11369606B2Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their useJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jun 28, 2022·1 cites·20 claims
- 0877US7122576B2Carbamate compounds for use in preventing or treating bipolar disorderPLATA-SALAMAN CARLOS R·Filed 2002·Granted Oct 17, 2006·16 cites·17 claims
- 0977US6815464B2Carbamate compounds for use in the treatment of painORTHO MCNEIL PHARM INC·Filed 2002·Granted Nov 9, 2004·7 cites·27 claims
- 1076US12048696B2Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their useJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Jul 30, 2024·0 cites·24 claims
- 1176US11103506B2Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their useJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Aug 31, 2021·0 cites·14 claims
- 1275US2022143141A1Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their useJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 1371US10537573B2Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their useJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Jan 21, 2020·1 cites·20 claims
- 1464US2011152362A1Methods of treating epileptogenesis and epilepsyCHOI YONG MOON·Filed 2007·Application pending·0 cites
- 1559US2009234003A1Carbamate compounds for use in preventing or treating anxiety disordersPLATA-SALAMAN CARLOS R·Filed 2009·Application pending·0 cites
- 1658US2009137652A1Methods for neuroprotectionTWYMAN ROY E·Filed 2009·Application pending·0 cites
- 1758US2009005442A1Carbamate compounds for use in preventing or treating neurodegenerative disordersPLATA-SALAMAN CARLOS R·Filed 2008·Application pending·0 cites
- 1854US2004171679A1Carbamate compounds for use in preventing or treating neurodegenerative disordersFiled 2004·Application pending·0 cites
- 1951US2007021500A1Methods for neuroprotectionTWYMAN ROY E·Filed 2006·Application pending·0 cites
- 2050US2005267203A1Carbamate compounds for use in preventing or treating anxiety disordersPLATA-SALAMAN CARLOS R·Filed 2005·Application pending·0 cites
- 2149US2002165273A1Carbamate compounds for use in preventing or treating neurodegenerative disordersFiled 2002·Application pending·0 cites
- 2249US2006194873A1Methods of treating epileptogenesis and epilepsyCHOI YONG M·Filed 2005·Application pending·0 cites
- 2343US2007021501A1Methods of treating epileptogenesisTWYMAN ROY E·Filed 2006·Application pending·0 cites
- 2438US6010854AAutoantibodies to neurotransmitter receptorsUNIV UTAH RES FOUND·Filed 1997·Granted Jan 4, 2000·8 cites·14 claims
- 2538US5731410APeptide for blocking autoantibody-evoked activation of glutamate receptor type 3 (GLUR3)UNIV UTAH RES FOUND·Filed 1994·Granted Mar 24, 1998·4 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Roy E. Twyman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →